ADNEXUS
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ADNEXUS Trademark

Serial Number: 85540626

ADNEXUS is a trademark filed by Adnexus, a Bristol-Myers Squibb R&D Company on February 13, 2012. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Adnexus, a Bristol-Myers Squibb R&D Company (18 trademarks)

100 Beaver Street
Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

February 13, 2012

Registration Date

Not Registered

Published for Opposition

May 8, 2012

Goods & Services

Biotechnology and pharmaceutical products, namely, therapeutic proteins for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Filing History

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Aug 5, 2013 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 5, 2013 ABN6
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 12, 2013 TCCA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 29, 2012 EXRA
SOU EXTENSION 1 GRANTED
Dec 27, 2012 EX1G
SOU EXTENSION 1 FILED
Dec 27, 2012 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 27, 2012 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 3, 2012 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2012 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2012 PREV
ASSIGNED TO LIE
Mar 31, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2012 CNSA
ASSIGNED TO EXAMINER
Mar 9, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 21, 2012 NWOS
NEW APPLICATION ENTERED
Feb 16, 2012 NWAP